2026 NPPES data Hematology & Oncology Physician NPI 1548410400 MD
Verify on CMS →

ALI SAYED, MD

Hematology & Oncology Physician in ATHENS, Georgia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
904
Medicare Part D claims · 146 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
68.3891/100
▼ 15 pts below national avg 83.1 · [object Object]
Industry payments
$1.5K
56 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ALI SAYED, MD reported a CMS MIPS final score of 68.3891/100 — below the 83.1 national average — and filed 904 Medicare Part D claims in 2023.

68.3891/100
MIPS score · -15 vs avg
904
Part D claims, 2023
79%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALI SAYED, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

68 7th percentile higher than 7% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). This entry sits in this band. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ALI SAYED, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALI SAYED, MD?

Below national average

NPI registry status

Active

Issued 09/26/2008

NPI 1548410400

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

904 7% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

68.3891/100 14.710899999999995% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Georgia

How Hematology & Oncology Physician compares to other specialties among Georgia providers

Georgia providers

Hematology & Oncology Physician share within Georgia

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Georgia

Medicare quality performance — MIPS

ALI SAYED, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
68.3891/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 68.3891/100 vs national avg 83.1

0%100%National avg83%68.4%
MIPS final score (Hematology & Oncology Physician) — 68.3891/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALI SAYED, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 125 KING AVE STE 200, ATHENS, GA, 30606, with a listed phone of (706) 369-4478. NPI 1548410400 was issued on 09/26/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SAYED most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 904 prescription claims written by this provider, covering 146 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 21% brand-name and 79% generic by claim count, with an opioid prescribing rate of 14.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 68.3891/100 for the 2023 performance year (Quality 70.8255, Cost 40.249), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

125 KING AVE STE 200
ATHENS, GA 30606

Provider Details

NPI 1548410400
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 09/26/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

68.3891
Final Score
Avg: 83.1
70.8255
Quality
40.249
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where ALI SAYED, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NSH CANCER INSTITUTE PROFESSIONAL SERVICES G LLC
ATHENS, GA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALI SAYED, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.5K

Largest payer

Takeda Pharmaceuticals U.S.A., Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

ALI SAYED, MD — brand share 21.0%
Specialty average (est.)

21% brand-name claims vs 79% generic, on 904 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

904
Total Claims
$1.8M
Total Drug Cost
146
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,118
Total Day Supply
27,057
Brand vs Generic
21% brand / 79% generic
Brand Drug Cost
$1.7M
Generic Drug Cost
$104K
Opioid Claims
128 (14.2% rate)
Antibiotic Claims
61

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
2.46
Gender Split
52% female / 48% male
Age Distribution
<65: 23, 65-74: 64, 75-84: 41, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALI SAYED, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
79
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
60
Gabapentin
49
Ondansetron Odt
Ondansetron
45
Anastrozole
40
Dexamethasone
36
Oxycodone Hcl
34
Acyclovir
32
Levofloxacin
30
Prochlorperazine Maleate
29

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How ALI SAYED, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

ALI SAYED, MD's 904 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Georgia

Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as SAYED.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALI SAYED, MD's specialty?
ALI SAYED, MD specializes in Hematology & Oncology Physician and practices in ATHENS, Georgia. Credentials: MD.
How much does ALI SAYED, MD prescribe under Medicare Part D?
In 2023, ALI SAYED, MD wrote 904 Medicare Part D claims totaling $1.8M in drug costs for 146 beneficiaries.
What is ALI SAYED, MD's Medicare quality score?
ALI SAYED, MD has a CMS MIPS Final Score of 68.3891/100 (Quality: 70.8255, Cost: 40.249). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ALI SAYED, MD located?
ALI SAYED, MD is located at 125 KING AVE STE 200, ATHENS, GA, 30606. Phone: (706) 369-4478.
What is ALI SAYED, MD's NPI number?
ALI SAYED, MD's National Provider Identifier (NPI) is 1548410400, issued on 09/26/2008.
Does ALI SAYED, MD prescribe more brand-name or generic drugs?
ALI SAYED, MD's prescribing is 21% brand-name and 79% generic drugs by claim count, with $1.7M in brand drug costs.
Does ALI SAYED, MD prescribe opioids?
Yes, ALI SAYED, MD had 128 opioid claims in 2023 with an opioid prescribing rate of 14.2%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does ALI SAYED, MD prescribe most often?
Based on 2023 Medicare Part D data, ALI SAYED, MD's most frequently prescribed drugs include Eliquis, Hydrocodone-Acetaminophen, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALI SAYED, MD accept Medicare?
ALI SAYED, MD appears in CMS Medicare data with 904 Part D claims and 146 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALI SAYED, MD's credentials?
ALI SAYED, MD's NPI is 1548410400 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology